Children's Oncology Group: all 447 studies

Page 4 of 5. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.

• Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid LeukemiaCompletedNCT01024127
• Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT01016379
• Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaCompletedNCT01005277
• Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms TumorsCompletedNCT01004783
• Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin LymphomaCompletedNCT01000753
• Study of Blood Samples From Newborns With Down SyndromeCompletedNCT00959283
• Study of Specimens From Young Patients With NeuroblastomaCompletedNCT00958659
• Study of Blood Samples From Patients With OsteosarcomaCompletedNCT00954473
• Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain TumorsCompletedNCT00919750
• Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue SarcomaCompletedNCT00919269
• Studying Tumor Samples From Young Patients With NeuroblastomaCompletedNCT00907920
• Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or GanglioneuroblastomaCompletedNCT00904241
• Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic LeukemiaWithdrawnNCT00900445
• Collecting and Storing Biological Samples From Young Patients With Hodgkin?s LymphomaCompletedNCT00900250
• Collecting and Storing Biological Samples From Patients With Ewing SarcomaCompletedNCT00899990
• Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or RemissionCompletedNCT00899899
• DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00899652
• Collecting and Storing Samples of Blood and Tumor Tissue From Patients With OsteosarcomaCompletedNCT00899275
• Collecting and Storing Tissue From Young Patients With CancerCompletedNCT00898755
• Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882CompletedNCT00898469
• Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With MethotrexateCompletedNCT00898404
• Study of DNA in Blood Samples From Patients With NeuroblastomaCompletedNCT00898391
• Study of Kidney Tumors in Younger PatientsCompletedNCT00898365
• Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With CancerCompletedNCT00898079
• Study of Tumor Samples From Patients With Ewing SarcomaCompletedNCT00898053
• Gene Expression Profiles to Categorize Wilms TumorsCompletedNCT00897637
• DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT00897507
• Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin LymphomaCompletedNCT00897325
• Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic LeukemiaCompletedNCT00896766
• Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialCompletedNCT00890435
• Neuropsychological and Behavioral Testing in Younger Patients With CancerCompletedNCT00772200
• Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell TransplantWithdrawnNCT00728585Phase 2
• Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated VolunteersCompletedNCT00690469
• Evaluating Dactinomycin and Vincristine in Young Patients With CancerCompletedNCT00674193
• Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00482352
• Assessing Ear Damage in Young Cancer Patients Treated With CisplatinCompletedNCT00458887
• Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWithdrawnNCT00458744Phase 1
• Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal ImagingCompletedNCT00445718
• Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic LeukemiaCompletedNCT00437060
• Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous ConditionsCompletedNCT00436696
• Registration and Informed Consent Study for the Childhood Cancer Research NetworkCompletedNCT00433394Not applicable
• Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative DisorderWithdrawnNCT00411281Phase 3
• Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade GliomaCompletedNCT00352495Phase 1
• Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for SarcomaWithdrawnNCT00334984Not applicable
• Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's SarcomaWithdrawnNCT00334867Phase 3
• Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell TransplantCompletedNCT00305851Phase 3
• Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in RemissionCompletedNCT00268528
• Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00138216Phase 1
• Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem GliomaTerminatedNCT00107471Phase 1/2
• Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS TumorsCompletedNCT00107458Phase 1
• Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic SyndromesCompletedNCT00098683Phase 2
• Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's LymphomaCompletedNCT00091091
• DNA Variations in the Gene in Young Patients With Wilms' TumorCompletedNCT00088803
• Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic LeukemiaCompletedNCT00085176
• Temozolomide in Treating Young Patients With Refractory or Recurrent LeukemiaCompletedNCT00083070Phase 1
• Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer SurvivorsCompletedNCT00082745
• Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationCompletedNCT00080873Not applicable
• High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade GliomasCompletedNCT00078988Phase 3
• Pemetrexed Disodium in Treating Young Patients With Recurrent Solid TumorsCompletedNCT00070473Phase 1
• Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's LymphomaCompletedNCT00070304Phase 2
• Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive NeuroblastomaCompletedNCT00070200Phase 1
• Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's LymphomaCompletedNCT00070187Phase 2/3
• Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification TherapyCompletedNCT00070174Phase 2
• Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell TumorsCompletedNCT00066482Not applicable
• Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic LeukemiaCompletedNCT00056069Not applicable
• Diagnostic Study of Tumor Characteristics in Patients With Ewing's SarcomaCompletedNCT00048984
• Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin LymphomaCompletedNCT00040911Not applicable
• Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host DiseaseCompletedNCT00031824Phase 3
• Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromesCompletedNCT00028899Phase 1
• Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine GliomaCompletedNCT00028795Phase 2
• Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201CompletedNCT00028509
• Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaCompletedNCT00022126Phase 2
• Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid LeukemiaCompletedNCT00021242Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed NeuroblastomaCompletedNCT00017368Phase 2
• Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid LeukemiaCompletedNCT00009698Phase 1
• Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving AnticonvulsantsCompletedNCT00008424Phase 1
• Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's LymphomaCompletedNCT00006760Phase 2
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal TumorCompletedNCT00006734Phase 3
• Ecteinascidin 743 in Treating Children With Refractory Solid TumorsCompletedNCT00006463Phase 1
• Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous LeukemiaCompletedNCT00006462Phase 2
• Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal TumorCompletedNCT00006461Phase 3
• Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00006095Phase 1
• Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant GliomaCompletedNCT00006024Phase 1
• Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic LeukemiaCompletedNCT00005977Phase 3
• Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005945Phase 3
• Quality of Life in Children Treated for CancerCompletedNCT00005881
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005603Phase 3
• Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem GliomasCompletedNCT00005602Phase 1
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00005596Phase 3
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005585Phase 3
• Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's DiseaseCompletedNCT00005578Phase 3
• STI571 in Treating Patients With Recurrent LeukemiaCompletedNCT00004932Phase 1
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With NeuroblastomaCompletedNCT00004188Phase 3
• Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00004078Phase 2
• Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00004056Phase 1
• Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's DiseaseCompletedNCT00004010Phase 2
• Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver CancerCompletedNCT00003994Phase 3
• Combination Chemotherapy in Treating Patients With Previously Untreated RhabdomyosarcomaCompletedNCT00003958Phase 3
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or SarcomaCompletedNCT00003955Phase 2
• Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic OsteosarcomaCompletedNCT00003937Phase 3

← Children's Oncology Group overview and focus areas